Table 6 Long-term Kidney and Survival outcomes in study patients (n = 11).
From: Sulfamethoxazole-induced crystal nephropathy: characterization and prognosis in a case series
NA | ||
|---|---|---|
Kidney outcomes | ||
Serum creatinine 3–6 months after crystalluria (µmol/L) | 1 | 126.5 [117.25–138.25] |
Glomerular filtration rate (GFR) 3–6 months after crystalluria (mL/min/1.73m2) (CKD-EPI) | 1 | 39 [33.575–56.35] |
Serum creatinine at last follow-up (µmol/L) | 2 | 152 [124–166] |
Glomerular filtration rate (GFR) at last follow-up (mL/min/1.73m2) (CKD-EPI) | 2 | 38 [32–48.4] |
End-stage renal disease (ESRD) | 2 | 1 (9.09%) |
Survival outcomes | ||
Death during hospitalization | 0 | 1 (9.09%) |
Death at last follow-up | 0 | 4 (36.36%) |
